Literature DB >> 19344474

Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.

A Gasbarrini1, G R Corazza, G Gasbarrini, M Montalto, M Di Stefano, G Basilisco, A Parodi, P Usai-Satta, P U Satta, P Vernia, C Anania, M Astegiano, G Barbara, L Benini, P Bonazzi, G Capurso, M Certo, A Colecchia, L Cuoco, A Di Sario, D Festi, C Lauritano, E Miceli, G Nardone, F Perri, P Portincasa, R Risicato, M Sorge, A Tursi.   

Abstract

BACKGROUND: Breath tests represent a valid and non-invasive diagnostic tool in many gastroenterological conditions. The rationale of hydrogen-breath tests is based on the concept that part of the gas produced by colonic bacterial fermentation diffuses into the blood and is excreted by breath, where it can be quantified easily. There are many differences in the methodology, and the tests are increasingly popular. AIM: The Rome Consensus Conference was convened to offer recommendations for clinical practice about the indications and methods of H2-breath testing in gastrointestinal diseases.
METHODS: Experts were selected on the basis of a proven knowledge/expertise in H2-breath testing and divided into Working Groups (methodology; sugar malabsorption; small intestine bacterial overgrowth; oro-coecal transit time and other gas-related syndromes). They performed a systematic review of the literature, and then formulated statements on the basis of the scientific evidence, which were debated and voted by a multidisciplinary Jury. Recommendations were then modified on the basis of the decisions of the Jury by the members of the Expert Group. RESULTS AND
CONCLUSIONS: The final statements, graded according to the level of evidence and strength of recommendation, are presented in this document; they identify the indications for the use of H2-breath testing in the clinical practice and methods to be used for performing the tests.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19344474     DOI: 10.1111/j.1365-2036.2009.03951.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  151 in total

1.  A review of rifaximin and bacterial overgrowth in poorly responsive celiac disease.

Authors:  Matthew S Chang; Peter H R Green
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

2.  Small intestinal bacterial overgrowth in patients with morbid obesity.

Authors:  Pauline Jouet; Benoit Coffin; Jean-Marc Sabate
Journal:  Dig Dis Sci       Date:  2011-02       Impact factor: 3.199

Review 3.  Gut microbiota and related diseases: clinical features.

Authors:  Vincenzo Stanghellini; Giovanni Barbara; Cesare Cremon; Rosanna Cogliandro; Alexandra Antonucci; Veronica Gabusi; Chiara Frisoni; Roberto De Giorgio; Valentina Grasso; Mauro Serra; Roberto Corinaldesi
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

4.  The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth.

Authors:  Scott L Gabbard; Brian E Lacy; Gary M Levine; Michael D Crowell
Journal:  Dig Dis Sci       Date:  2013-12-10       Impact factor: 3.199

Review 5.  Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth.

Authors:  S C Shah; L W Day; M Somsouk; J L Sewell
Journal:  Aliment Pharmacol Ther       Date:  2013-09-04       Impact factor: 8.171

6.  Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance.

Authors:  Mercedes Amieva-Balmori; Enrique Coss-Adame; Nikilesh S Rao; Brisa M Dávalos-Pantoja; Satish S C Rao
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

7.  Can we shorten the lactose tolerance test?

Authors:  J L Domínguez Jiménez; A Fernández Suárez
Journal:  Eur J Clin Nutr       Date:  2013-11-27       Impact factor: 4.016

8.  Pediatric small intestine bacterial overgrowth in low-income countries.

Authors:  Jeffrey R Donowitz; William A Petri
Journal:  Trends Mol Med       Date:  2014-11-15       Impact factor: 11.951

9.  Consequences of Small Intestinal Bacterial Overgrowth in Obese Patients Before and After Bariatric Surgery.

Authors:  Jean-Marc Sabate; Muriel Coupaye; Séverine Ledoux; Benjamin Castel; Simon Msika; Benoit Coffin; Pauline Jouet
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

10.  [Abdominal spasms, meteorism, diarrhea: fructose intolerance, lactose intolerance or IBS?].

Authors:  Margaritha Litschauer-Poursadrollah; Sabine El-Sayad; Felix Wantke; Christina Fellinger; Reinhart Jarisch
Journal:  Wien Med Wochenschr       Date:  2012-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.